Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review.
|
Toxicol Appl Pharmacol
|
2005
|
2.45
|
2
|
LifeMap Discovery™: the embryonic development, stem cells, and regenerative medicine research portal.
|
PLoS One
|
2013
|
1.14
|
3
|
The DXPas34 repeat regulates random and imprinted X inactivation.
|
Dev Cell
|
2007
|
1.08
|
4
|
Cell-based therapy approaches: the hope for incurable diseases.
|
Regen Med
|
2014
|
0.87
|
5
|
Distribution and accumulation of a mixture of arsenic, cadmium, chromium, nickel, and vanadium in mouse small intestine, kidneys, pancreas, and femur following oral administration in water or feed.
|
J Toxicol Environ Health A
|
2002
|
0.87
|
6
|
Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation.
|
Lab Invest
|
2004
|
0.85
|
7
|
The effect of polycyclic aromatic hydrocarbons on the degradation of benzo[a]pyrene by Mycobacterium sp. strain RJGII-135.
|
Environ Toxicol Chem
|
2002
|
0.82
|
8
|
Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes.
|
Toxicol Lett
|
2003
|
0.79
|
9
|
Impact of Cyp1a2 or Ahr gene knockout in mice: implications for biomonitoring studies.
|
Toxicol Lett
|
2005
|
0.79
|
10
|
Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies.
|
Pathobiology
|
2004
|
0.79
|
11
|
TNP-470 inhibits 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation when administered before the formation of carcinoma in situ but is not additive with tamoxifen.
|
Lab Invest
|
2003
|
0.78
|
12
|
A metabolic activation mechanism of 7H-dibenzo[c,g]carbazole via o-quinone. Part 2: covalent adducts of 7H-dibenzo[c,g]carbazole-3,4-dione with nucleic acid bases and nucleosides.
|
Chem Res Toxicol
|
2002
|
0.76
|